AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
Tax period
2019-06-01 to 2020-05-31
Filed
2021-03-19
IRS object ID
202100789349300900
Schema version
2019v5.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-03-19T08:05:26-05:00ReturnTs
Tax Period End2020-05-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN420714325PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1RSM US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line12021 L STREET NW SUITE 400AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20036ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-06-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN237033369EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEMBusinessNameLine1Txt
Business Name Line2PHARMACISTS RESEARCH AND EDUCATION FDTNBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlAMERBusinessNameControlTxt
Phone3016648612PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY NO 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSTEVEN RUBLOFFPersonNm
Person TitleSECRETARY AND CEOPersonTitleTxt
Phone3016648612PhoneNum
Signature2021-03-19SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonELIZABETH W HELLERPreparerPersonNm
PTINP00397829PTIN
Phone2022932200PhoneNum
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1ASHP FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerSTEVEN RUBLOFFPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY NO 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$2,943,234GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.ASHPFOUNDATION.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1968FormationYr
Legal Domicile StateMDLegalDomicileStateCd
Activity Or MissionTHE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.ActivityOrMissionDesc
Voting Members Governing Body12VotingMembersGoverningBodyCnt
Voting Members Independent9VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers125TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,768,602PYContributionsGrantsAmt
CY Contributions Grants$928,082CYContributionsGrantsAmt
PY Program Service Revenue$512,137PYProgramServiceRevenueAmt
CY Program Service Revenue$1,118,585CYProgramServiceRevenueAmt
PY Investment Income$483,729PYInvestmentIncomeAmt
CY Investment Income$325,684CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$2,764,468PYTotalRevenueAmt
CY Total Revenue$2,372,351CYTotalRevenueAmt
PY Grants And Similar Paid$476,870PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$432,880CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,411,898PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,503,470CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$747,211CYTotalFundraisingExpenseAmt
PY Other Expenses$704,553PYOtherExpensesAmt
CY Other Expenses$649,631CYOtherExpensesAmt
PY Total Expenses$2,593,321PYTotalExpensesAmt
CY Total Expenses$2,585,981CYTotalExpensesAmt
PY Revenues Less Expenses$171,147PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$213,630CYRevenuesLessExpensesAmt
Total Assets BOY$10,276,086TotalAssetsBOYAmt
Total Assets EOY$9,865,167TotalAssetsEOYAmt
Total Liabilities BOY$854,211TotalLiabilitiesBOYAmt
Total Liabilities EOY$864,752TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$9,421,875NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$9,000,415NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOUR MISSION:SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$920,408ExpenseAmt
Grant$194,985GrantAmt
Revenue$610,795RevenueAmt
DescEXCELLENCE IN PHARMACY PRACTICE & LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACYASHP STUDENT LEADERSHIP AWARD THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. NINE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. RECIPIENTS WERE: CLASS OF 2020 - LEAH SELZNICK, VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF PHARMACY, FALLS CHURCH, VA; JESSICA SHELLEY, OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY, ADA, OHCLASS OF 2021 - UZO ABAJUE, TEXAS SOUTHERN UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES, HOUSTON, TX; ALFRED AWUAH, UNIVERSITY OF GEORGIA COLLEGE OF PHARMACY, AUGUSTA, GA; AMY GUISINGER, UNIVERSITY OF NORTH CAROLINA ESHELMAN SCHOOL OF PHARMACY-CHAPEL HILL, CHAPEL HILL, NC; MORGAN JONES, UNIVERSITY OF CINCINNATI JAMES L.WINKLE COLLEGE OF PHARMACY, CINCINNATI, OH; AMEE JOSHI, THE OHIO STATE UNIVERSITY COLLEGE OF PHARMACY, COLUMBUS, OH; KAVEH OLOUMI, MIDWESTERN UNIVERSITY COLLEGE OF PHARMACY-GLENDALE, GLENDALE, AZCLASS OF 2021 - ATHENA TRIGLIA,OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY, ADA, OHTHE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAMTHE 2019 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED AGAIN BY AMGEN, INC. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPIC THAT CONTINUING EDUCATION CREDITS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. THE 2019 PROGRAM AND THE RECIPIENTS WERE:NEW PRECEPTOR: KATIE E. KORTE, PHARM.D., BCPS, BCCCP, TRUMAN MEDICAL CENTERS, KANSAS CITY, MOPRECEPTOR: JOEL C. MARRS, PHARM.D., BCPS, BCACP, BCCP, CLS, ASH-CHC, UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, AURORA, COPROGRAM: UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, PGY2, AMBULATORY CARE, AURORA, COLITERATURE AWARDS PROGRAMTHE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, IS BASED ON THE CONCEPT THAT RECOGNITION THROUGH AWARDS STIMULATES RESEARCH AND INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES ARE RECOGNIZED AT THE ASHP MIDYEAR CLINICAL MEETING DURING THE SPOTLIGHT ON SCIENCE PLENARY SESSION. THE 2019 RECIPIENTS WERE: SUSTAINED CONTRIBUTIONSVINCENT H. TAM, PHARM.D., FIDA, BCPS, UNIVERSITY OF HOUSTONPHARMACY PRACTICE RESEARCH "IMPACT OF A PHARMACIST-PHYSICIAN COLLABORATIVE CARE MODEL ON PATIENT OUTCOMES AND HEALTH SERVICES UTILIZATION"AM J HEALTH SYST PHARM. 2018 75GARY R. MATZKE, B.S.PHARM., PHARM.D., LETICIA R. MOCZYGEMBA, PHARM.D., KAREN J. WILLIAMS, PHARM.D., MICHAEL J. CZAR, B.S.PHARM., PH.D., WILLIAM T. LEE, B.S.PHARM., M.P.A.INNOVATION IN PHARMACY PRACTICE"IMPACT OF REQUIRING RE-AUTHORIZATION OF RESTRICTED ANTIBIOTICS ON DAY 3 OF THERAPY"J ANTIMICROB CHEMOTHER. 2018; 73:KHALID ELJAALY, SALWA ELARABI, SAMAH ALSHEHRI, AND DAVID E. NIX DRUG THERAPY RESEARCH "ASSOCIATION OF INHALED CORTICOSTEROIDS AND LONG-ACTING MUSCARINIC ANTAGONISTS WITH ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, PERSISTENT ASTHMA A SYSTEMATIC REVIEW AND META-ANALYSIS"JAMA. 2018;319DIANA M. SOBIERAJ, PHARMD; WILLIAM L. BAKER, PHARMD; ELAINE NGUYEN, PHARMD, MPH; ERIN R. WEEDA, PHARMD; CRAIG I. COLEMAN, PHARMD; C. MICHAEL WHITE, PHARMD; STEPHEN C. LAZARUS, MD; KATHRYN V. BLAKE, PHARMD; JASON E. LANG, MD, MPH STUDENT RESEARCH AWARD"PHARMACOTHERAPY-INDUCED HEPATITIS B REACTIVATION AMONG PATIENTS WITH PRIOR FUNCTIONAL CURE: A SYSTEMATIC REVIEW"ANNALS OF PHARMACOTHERAPY. 2019; 53. 2018;7RHIANNON M. BATH, BRANDELYN E. DOERING, MICHAEL D. NAILOR, PHARMD,, KELLIE J. GOODLET, PHARMDEDUCATION PROGRAMSTRAINEESHIPSIN FY20, THE FOUNDATION ADMINISTERED ONE TRAINEESHIP. PAIN AND PALLIATIVE CARE TRAINEESHIP THE PAIN AND PALLIATIVE CARE TRAINEESHIP INCLUDED ACCESS TO THE ASHP PAIN MANAGEMENT CERTIFICATE AND LIVE CASE-BASED WEBINARS, AN EXPERIENTIAL TRAINING COMPONENT, AND A POST-TRAINEESHIP PROJECT COMPONENT, WHICH WAS SUPPORTED THROUGH PARTICIPANT TUITION. IN FY20, 6 PHARMACISTS WERE ACCEPTED INTO THE TRAINEESHIP. DUE TO COVID19 RESTRICTIONS AND CONCERNS, THE DISTANCE EDUCATION WAS POSTPONED AND WILL BE SCHEDULED IN FY21. OTHER EDUCATIONAL PROGRAMSJOSEPH A. ODDIS COLLOQUIUMTHE COLLOQUIUM WAS ESTABLISHED TO PAY TRIBUTE TO ONE OF PHARMACY'S MOST DISTINGUISHED LEADERS AND ASSIST HEALTH-SYSTEM PHARMACISTS IN CONFRONTING ETHICAL CHALLENGES IN PHARMACY PRACTICE AND PATIENT CARE. THE 2019 COLLOQUIUM WAS OFFERED AS A LIVE EDUCATIONAL ACTIVITY PLANNED FOR THE 2019 ASHP SUMMER MEETINGS. PHARMACY RESIDENCY EXPANSION GRANTIN FY20, THE ASHP FOUNDATION, SUPPORTED BY EDUCATIONAL DONATIONS FROM ABBVIE AND MERCK, AWARDED $125,000 DOLLARS IN GRANTS TO PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. THERE WERE 5 GRANTS AWARDED. RECIPIENTS WERE: PARKVIEW HEALTH, BAPTIST HEALTH FLOYD, UNIVERSITY OF ILLINOIS AT CHICAGO COLLEGE OF PHARMACY AT ROCKFORD, GEISINGER MEDICAL CENTER, AND UNIVERSITY OF MARYLAND MEDICAL CENTER PHARMACY STUDENT CLINICAL SKILLS COMPETITIONMARY CASH AND SARA SCOTT, UNIVERSITY OF NORTH CAROLINA ESHELMAN SCHOOL OF PHARMACY COMPETED AGAINST OTHER TEAMS AT THE 2019 ASHP NATIONAL CLINICAL SKILLS COMPETITIONSM, HELD IN DECEMBER 2019, DURING THE ASHP MIDYEAR CLINICAL MEETING IN LAS VEGAS, NV. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING 14 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$666,743ExpenseAmt
Grant$237,895GrantAmt
DescINNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $7,500 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM THIS GRANT PROGRAM IS FUNDED THROUGH THE ASHP MEMBER DUES CONTRIBUTION TO THE FOUNDATION. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 8 GRANTS UP TO $5,000 EACH FOR:"CLINICAL AND ECONOMIC IMPACT OF INCORPORATING A PHARMACY TECHNICIAN INTO A MEDICATION MONITORING PROGRAM"HLEE LOR, PHARM.D KAISER PERMANENTE COLORADO, DENVER, CO "EVALUATION OF A PHARMACIST-LED OUTPATIENT ANTIBIOTIC STEWARDSHIP PROGRAM AND IMPLEMENTATION OF PRESCRIBING ORDER SETS" CURTIS BLOW, PHARM.D SUNY UPSTATE MEDICAL UNIVERSITY - UPSTATE HEALTH CARE CENTER, SYRACUSE, NY"ASSESSING THE IMPACT OF RURALBASED AMBULATORY PHARMACIST ON DIABETES CARE THROUGH PERCEPTIONS OF ADVANCED MONITORING TECHNOLOGIES" JEREMY SPARKS, PHARM.DUNIVERSITY OF FLORIDA, GAINESVILLE, FL"DEVELOPMENT AND VALIDATION OF A PHARMACIST TRANSITIONS OF CARE TOOL USING MACHINE LEARNING ALGORITHMS TO PREDICT REHOSPITALIZATION IN CHRONIC HEART FAILURE" MELISSA RIESTER, PHARM.D RHODE ISLAND HOSPITAL, PROVIDENCE, RI"DEVELOPMENT OF A NOVEL PHARMACIST-LED OPIOID DEPRESCRIBING PROTOCOL FOR OLDER ADULTS"ALISSA MARGRAF, PHARM.DRHODE ISLAND HOSPITAL/LIFESPAN PHARMACY, PROVIDENCE, RI"PHARMACIST-DRIVEN FLUID STEWARDSHIP IN THE NEUROINTENSIVE CARE"BROOKE BARLOW, PHARM.DUNIVERSITY OF KENTUCKY HEALTHCARE, LEXINGTON KY"EXPANDING SERVICES OF A PHARMACIST-LED RURAL MOBILE HEALTH CLINIC TO SCHOOL-AGED CHILDREN AND WORKING CLASS PARENTS" MEGAN STEPHAN, PHARM.DOHIO NORTHERN UNIVERSITY, ADA, OH"IMPLEMENTATION AND EVALUATION OF AN ABC INVENTORY MODEL IN A CANCER CENTER PHARMACY AT A LARGE ACADEMIC MEDICAL CENTER"ROBERT ROSE UNIVERSITY OF NORTH CAROLINA MEDICAL CENTER, CHAPEL HILL, NCPHARMACY PRACTICE ADVANCEMENT DEMONSTRATION GRANTTWELVE LETTER OF INTENT AND FULL APPLICATIONS WERE REVIEWED BY EXTERNAL REVIEW PANEL IN ORDER TO AWARD THE FY20 GRANTEES. THIS RESEARCH GRANT PROGRAM SUPPORTS DEMONSTRATION PROJECTS RELATED TO PRACTICE ADVANCEMENT, CONSISTENT WITH THE ASHP/ASHP FOUNDATION PRACTICE ADVANCEMENT INITIATIVE. GRANT FUNDS WERE PROVIDED BY THE BAXTER ENDOWMENT AND EACH GRANTEE WAS AWARDED UP TO $75,000. "IMPACT OF AN INTEGRATED PHARMACIST AND PRIMARY CARE COLLABORATIVE TRANSITIONS OF CARE PROGRAM ON CLINICAL AND ECONOMIC OUTCOMES AMONG HIGH RISK PATIENTS" INVESTIGATOR DAVID JACOBS, PHARM.D., PH.D.UNIVERSITY AT BUFFALO SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES, BUFFALO, NY"AN EVALUATION OF THE CLINICAL IMPACT OF PHARMACIST IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM IN A PRIMARY CARE SETTING: A PILOT STUDY"INVESTIGATOR: ARINZE NKEMDIRIM OKERE, PHARM.D.FLORIDA A&M UNIVERSITY, TALLAHASSEE, FLNEW PRACTITIONER PHARMACIST LEADERSHIP DEVELOPMENT RESEARCH GRANT PROGRAM THIS NEW GRANT PROGRAM, FUNDED THROUGH THE MARIANNE F. IVEY LEADERSHIP DEVELOPMENT FUND, AWARDS NEW PRACTITIONER PHARMACISTS TO SUPPORT DIVERSE PROJECTS RELATED TO LEADERSHIP DEVELOP RESEARCH. AREAS OF FOCUS INCLUDE, MODEL DEMONSTRATION PROJECTS, SYSTEMS CHANGE PROJECTS, SPECIAL STUDIES AND EVALUATIONS THAT ARE FOCUSED ON DEVELOPING LEADERSHIP COMPETENCIES. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 4 GRANTS UP TO $5,000 EACH FOR:"EVALUATING THE EFFECTS OF A MINDFULNESS MOBILE APPLICATION ON STUDENT PHARMACISTS' STRESS, MINDFULNESS AND BURNOUT."ANGELA CHU, PHARM.D, BCPS ROSEMAN UNIVERSITY OF HEALTH SCIENCES, HENDERSON, NV"EVALUATION OF BURNOUT AMONG PHARMACY RESIDENTS IN THE UNITED STATES."DEREK GYORI, PHARM. D., BCOP UNIVERSITY OF TOLEDO COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES,TOLEDO, OH"THE EFFECT OF SELF-LEADERSHIP ON BURNOUT AMONG PGY-1 PHARMACY PRACTICE RESIDENTS"CHIEMENA OHANELE, PHARM.D, RPH HOWARD UNIVERSITY COLLEGE OF PHARMACY, WASHINGTON, DC"THE EFFECT OF SELF-LEADERSHIP ON BURNOUT AMONG PGY-1 PHARMACY PRACTICE RESIDENTS"STACY PASCIOLLA, PHARM.D UNIVERSITY OF THE SCIENCES, PHILADELPHIA, PARESEARCH ADVISORY COUNCIL IN FY20, THE ASHP FOUNDATION ESTABLISHED A RESEARCH ADVISORY COUNCIL TO GUIDE THE FOCUS AND EXPANSION OF OUR RESEARCH PROGRAM. THE COUNCIL MET AT ASHP HEADQUARTERS IN JANUARY 2020 AND DEVELOPED A RESEARCH AGENDA FRAMEWORK OF CORE PRINCIPLES AND PRIORITY RESEARCH AREAS THAT ALIGN WITH THE FOUNDATION'S MISSION AND ASHP'S MAJOR PRIORITIES AND ARE AT THE FOREFRONT OF THE NATIONAL HEALTHCARE AGENDA. TOOLS AND RESOURCESHARVEY A. K. WHITNEY AWARD LECTURES ONLINE COLLECTION PROGRAMTHE HARVEY A.K. WHITNEY AWARD IS THE MOST PRESTIGIOUS AWARD IN HEALTH-SYSTEM PHARMACY. THE WHITNEY AWARD LECTURES ONLINE COLLECTION PROGRAM INCLUDES A WEBSITE FOR DISSEMINATION OF WHITNEY LECTURES. THE WEBSITE PROVIDES ACCESS TO MORE THAN 60 LECTURES THAT CAN BE BROWSED BY TITLE, AUTHOR, PUBLICATION DATE OR KEYWORD. THESE LECTURES REPRESENT MORE THAN 50 YEARS OF EXCELLENCE IN PHARMACY PRACTICE, PROVIDING A UNIQUE GLIMPSE INTO OUR COLLECTIVE PAST, A COMMENTARY ON THE PRESENT, AND AN OUTLINE OF THE CHALLENGES AND OPPORTUNITIES THAT LIE AHEAD. LEADERSHIP PROGRAMSPHARMACY FORECAST REPORT 2020THE 2020 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2020 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 55,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2019 AND PRESENTED AT AN EDUCATIONAL SESSION DURING THE 2019 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY. IT ALSO INCLUDED A CHAPTER ON "BLACK SWAN" EVENTS AND ITS IMPACT ON PHARMACY. VISITING LEADERS PROGRAM (VLP)THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. ELEVEN LEADERS WERE INVOLVED IN 14 RESIDENCY VISITS, REACHING MORE HUNDREDS OF RESIDENTS IN 14 STATES IN FY20. THE PROGRAM OFFERS AN HONORARIUM AND TRAVEL EXPENSE REIMBURSEMENT TO THE PHARMACIST LEADERS TO CONDUCT THE 2-DAY VISIT TO SELECTED RESIDENCY PROGRAMS. AN ADDITIONAL 7 VISITS WERE POSTPONED BECAUSE OF COVID19 AND WILL BE RESCHEDULED IN FY21.PHARMACY LEADERSHIP ACADEMY (PLA) THE PLA, SUPPORTED IN PART BY AN EDUCATIONAL GRANT FROM AMGEN, INC. AND APEXIS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS. THE PLA CLASS IN FY20 CONSISTED OF 100 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2019 JUNE 2020. THE NUMBER OF GRADUATES IN BRINGS THE TOTAL NUMBER OF PLA GRADUATES TO 866 PHARMACISTS.STUDENT LEADERSHIP DEVELOPMENT WORKSHOP THE 3-HOUR LEADERSHIP DEVELOPMENT WORKSHOP FOR PHARMACY STUDENTS IS CONDUCTED ANNUALLY AT THE ASHP SUMMER MEETINGS. STATE AFFILIATES HAVE TAKEN ADVANTAGE OF THE PROGRAM TO ENGAGE STUDENTS AT THEIR ANNUAL MEETINGS. NO WORKSHOPS WERE SCHEDULED IN FY20 BECAUSE OF COVID19. LEADERSHIP SPEAKERS BUREAUA PROGRAM DESIGNED TO HAVE PHARMACY LEADERS SPEND ONE DAY WITH STUDENTS IN A LOCAL SCHOOL OF PHARMACY'S STUDENT SOCIETY OF HEALTH-SYSTEM PHARMACISTS (SSHP) TO DISCUSS EMERGING LEADERSHIP TOPICS. THE SSHP'S HAVE THE OPPORTUNITY TO SUBMIT RECEIPTS FOR REIMBURSEMENT OF UP TO $200 TO HELP COVER EXPENSES DURING THE VISIT. NO SSHP SUBMITTED EXPENSES FOR REIMBURSEMENT IN FY20. THE WILLIAM A. ZELLMER LECTURE A DISTINGUISHED SPEAKER IS INVITED TO ADDRESS THE PRACTICE LEADERS OF ASHP DURING ASHP POLICY WEEK ON AN ANNUAL BASIS. THROUGH THE LECTURE FUND, HEALTH-SYSTEM PHARMACY LEADERS FROM AROUND THE COUNTRY WILL CONTINUE TO BE INSPIRED AND CONFRONTED BY LEADING THINKERS REGARDING CONCERNS FACING PHARMACY AND HEALTHCARE. ERIN R. FOX, SENIOR DIRECTOR OF DRUG INFORMATION AND SUPPORT SERVICES AT UNIVERSITY OF UTAH HEALTH, HAS ADVICE FOR PHARMACY COLLEAGUES ABOUT HOW TO SHAPE POLICY AND DRIVE NATIONAL CONVERSATIONS ON ISSUES THAT ARE IMPORTANT TO THE PROFESSION. "THINK BIG. YOU CAN MAKE A DIFFERENCE," SHE SAID SEPT. 10 WHILE PRESENTING THE 2019 WILLIAM A. ZELLMER LECTURE IN BETHESDA, MARYLAND.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Revenue$476,790RevenueAmt
DescTHE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$1,587,151TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgYes (1)TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document61IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members12GoverningBodyVotingMembersCnt
Independent Voting Member9IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of Committees0MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1TRACY YAKLYVICHBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone3016648696PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY SUITE 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
JOHN T TIGHE III
CHAIR1.000.00Yes (X)Yes (X)$0$0$0
R EDWARD HOWELL
VICE CHAIR1.000.00Yes (X)Yes (X)$0$0$0
PAUL W ABRAMOWITZ
PRESIDENT/ASHP CEO3.0037.50Yes (X)Yes (X)$0$917,893$54,033
CHRISTENE JOLOWSKY
TREASURER1.004.00Yes (X)Yes (X)$0$0$0
THOMAS J JOHNSON
TREASURER (THRU 8/19); ASHP PRESIDENT-ELECT1.005.00Yes (X)Yes (X)$0$0$0
STEVEN A RUBLOFF
SECY/ASHP REF CEO40.000.00Yes (X)Yes (X)$337,637$0$45,552
ROGER W ANDERSON
DIRECTOR AT LARGE1.000.00Yes (X)$0$0$0
MINNIE BAYLOR-HENRY
DIRECTOR AT LARGE1.000.00Yes (X)$0$0$0
JANET L MIGHTY
DIRECTOR AT LARGE1.000.00Yes (X)$0$0$0
KEN PEREZ
DIRECTOR AT LARGE1.000.00Yes (X)$0$0$0
THOMAS J RICE
DIRECTOR AT LARGE1.000.00Yes (X)$0$0$0
SCOTT M SAMSON
DIRECTOR AT LARGE1.000.00Yes (X)$0$0$0
KELLY M SMITH
DIRECTOR AT LARGE1.005.00Yes (X)$0$10,150$0
KATHLEEN S PAWLICKI
ASHP PRESIDENT1.005.00Yes (X)$0$10,150$0
BARBARA NUSSBAUM
VP FOR RESEARCH AND EDUCATION40.000.00$180,091$0$52,876Yes (X)
STEPHANIE BROWN
DIRECTOR, FOUNDATION OPERATIONS40.000.00$117,258$0$22,610Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$634,986TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$938,193TotReportableCompRltdOrgAmt
Total Other Compensation$175,071TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Related Organizations$357,100RelatedOrganizationsAmt
All Other Contributions$570,982AllOtherContributionsAmt
Total Contributions$928,082TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
PHARMACY LEADERSHIP AC611430$605,295$605,295
CORPORATE PARTNER PROG611430$476,790$476,790
SPONSORSHIPS900099$31,000$31,000
PAIN & PALLIATIVE TRAI611430$5,500$5,500
FieldValueIRS element (for citing)
Total Program Service Revenue$1,118,585TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$303,024TotalRevenueColumnAmt
Exclusion$303,024ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$593,543SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$570,883SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$22,660SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$22,660TotalRevenueColumnAmt
Exclusion$22,660ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,372,351TotalRevenueColumnAmt
Related Or Exempt Func Income$1,087,585RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$356,684ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$397,535TotalAmt
Program Services$397,535ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$35,345TotalAmt
Program Services$35,345ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$388,499TotalAmt
Program Services$187,039ProgramServicesAmt
Management And General$28,901ManagementAndGeneralAmt
Fundraising$172,559FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$850,258TotalAmt
Program Services$409,803ProgramServicesAmt
Management And General$61,581ManagementAndGeneralAmt
Fundraising$378,874FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$105,393TotalAmt
Program Services$56,955ProgramServicesAmt
Management And General$9,166ManagementAndGeneralAmt
Fundraising$39,272FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$86,780TotalAmt
Program Services$39,939ProgramServicesAmt
Management And General$7,600ManagementAndGeneralAmt
Fundraising$39,241FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$72,540TotalAmt
Program Services$36,524ProgramServicesAmt
Management And General$4,456ManagementAndGeneralAmt
Fundraising$31,560FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$12,500TotalAmt
Management And General$12,500ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$420,434TotalAmt
Program Services$314,350ProgramServicesAmt
Management And General$75,953ManagementAndGeneralAmt
Fundraising$30,131FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$52,764TotalAmt
Program Services$45,299ProgramServicesAmt
Management And General$6,859ManagementAndGeneralAmt
Fundraising$606FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,100TotalAmt
Management And General$1,100ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$126,878TotalAmt
Program Services$58,202ProgramServicesAmt
Management And General$17,113ManagementAndGeneralAmt
Fundraising$51,563FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$24,496TotalAmt
Management And General$24,496ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp

FieldValueIRS element (for citing)
DescGENERAL EXPENSESDesc
Total$11,459TotalAmt
Program Services$6,160ProgramServicesAmt
Management And General$1,894ManagementAndGeneralAmt
Fundraising$3,405FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$2,585,981TotalAmt
Program Services$1,587,151ProgramServicesAmt
Management And General$251,619ManagementAndGeneralAmt
Fundraising$747,211FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$81,749BOYAmt
EOY$160,544EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$189,363BOYAmt
EOY$21,418EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$602,196BOYAmt
EOY$401,165EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$242,712BOYAmt
EOY$40,644EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$283,347LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$97,081LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$11,398BOYAmt
EOY$186,266EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$8,971,882BOYAmt
EOY$8,914,470EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$161,768BOYAmt
EOY$125,642EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$15,018BOYAmt
EOY$15,018EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,276,086BOYAmt
EOY$9,865,167EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$277,949BOYAmt
EOY$307,673EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$576,262BOYAmt
EOY$557,079EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$854,211BOYAmt
EOY$864,752EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,471,468BOYAmt
EOY$1,506,384EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$7,950,407BOYAmt
EOY$7,494,031EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$9,421,875BOYAmt
EOY$9,000,415EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,276,086BOYAmt
EOY$9,865,167EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$213,630ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$207,830NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consol And Sep Basis Fincl StmtYes (X)ConsolAndSepBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,055,036CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,799,986CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,088,349CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,768,602CurrentTaxYearMinus1YearAmt
Current Tax Year$928,082CurrentTaxYearAmt
Total$8,640,055TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,055,036CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,799,986CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,088,349CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,768,602CurrentTaxYearMinus1YearAmt
Current Tax Year$928,082CurrentTaxYearAmt
Total$8,640,055TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$3,945,100SubstantialContributorsTotAmt
Public Support Total170$4,694,955PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$294,198CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$270,016CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$315,175CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$406,338CurrentTaxYearMinus1YearAmt
Current Tax Year$303,024CurrentTaxYearAmt
Total$1,588,751TotalAmt
FieldValueIRS element (for citing)
Total Support$10,228,806TotalSupportAmt
Gross Receipts Rltd Activities$3,442,131GrossReceiptsRltdActivitiesAmt
Public Support CY1700.45900PublicSupportCY170Pct
Public Support PY1700.47510PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,808,429BeginningYearBalanceAmt
Contributions$1,300ContributionsAmt
Investment Earnings Or Losses$106,680InvestmentEarningsOrLossesAmt
Other Expenditures$185,232OtherExpendituresAmt
End Year Balance$6,731,177EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,838,821BeginningYearBalanceAmt
Contributions$1,480ContributionsAmt
Investment Earnings Or Losses$93,478InvestmentEarningsOrLossesAmt
Other Expenditures$125,350OtherExpendituresAmt
End Year Balance$6,808,429EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,732,965BeginningYearBalanceAmt
Contributions$6,019ContributionsAmt
Investment Earnings Or Losses$423,554InvestmentEarningsOrLossesAmt
Other Expenditures$323,717OtherExpendituresAmt
End Year Balance$6,838,821EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,264,149BeginningYearBalanceAmt
Contributions$291,302ContributionsAmt
Investment Earnings Or Losses$654,392InvestmentEarningsOrLossesAmt
Other Expenditures$476,878OtherExpendituresAmt
End Year Balance$6,732,965EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,403,208BeginningYearBalanceAmt
Contributions$1,700ContributionsAmt
Investment Earnings Or Losses-$65,917InvestmentEarningsOrLossesAmt
Other Expenditures$74,842OtherExpendituresAmt
End Year Balance$6,264,149EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.07430BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.75660PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.16910TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$83,984OtherCostOrOtherBasisAmt
Depreciation$77,145DepreciationAmt
Book Value$6,839BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$199,363OtherCostOrOtherBasisAmt
Depreciation$19,936DepreciationAmt
Book Value$179,427BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$186,266TotalBookValueLandBuildingsAmt
Total Rev Etc Audited Fincl Stmt$2,411,124TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$207,830NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$246,603DonatedServicesAndUseFcltsAmt
Revenue Not Reported$38,773RevenueNotReportedAmt
Revenue Subtotal$2,372,351RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$2,372,351TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$2,832,584TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$246,603DonatedServicesUseFcltsAmt
Expenses Not Reported$246,603ExpensesNotReportedAmt
Expenses Subtotal$2,585,981ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$2,585,981TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART V, LINE 4:FormAndLineReferenceDesc
ExplanationTHE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (14 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION
ONE CHURCH STREETROCKVILLEMD20850530214882501(C)3$7,5002019 SPONSORSHIP
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISITS
4500 EAST-WEST HIGHWAYBETHESDAMD20814520807628501(C)6$34,640CLINICAL SKILLS COMPETITION
EDWARD VIA VIRGINIA COLLEGE OF OSTEOPATHIC MEDICINE
2265 KRAFT DRIVEBLACKSBURGVA24060542052107501(C)3$6,800NEW INVESTIGATOR RESEARCH GRANT
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
109 KINKEAD HALLLEXINGTONKY40506616033693501(C)3$6,611NEW INVESTIGATOR RESEARCH GRANT
PURDUE UNIVERSITY
1281 WIN HENTSCHEL BLVDWEST LAFAYETTEIN47906356002041501(C)3$25,3882016 PHARMACY PRACTICE MODEL GRANT
DENT NEUROSCIENCES RESEARCH CENTER INC
3980 SHERIDAN DRIVE SUITE 500AMHERSTNY14226161583617501(C)3$23,3822019 PRACTICE ADVANCEMENT DEMO GRANT
UNIVERSITY OF TENNESSEE
201 ANDY HOLT TOWERKNOXVILLETN37996626001636501(C)3$24,7502019 PRACTICE ADVANCEMENT DEMO GRANT
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK
PO BOX 9ALBANYNY12201141368361501(C)3$24,7502019 PRACTICE ADVANCEMENT DEMO GRANT
FLORIDA A&M UNIVERSITY
1700 LEE HALL DRIVETALLAHASSEEFL32307590977035STATE AGENCY$24,7502019 PRACTICE ADVANCEMENT DEMO GRANT
GEISINGER MEDICAL CENTER
100 NORTH ACADEMY AVENUEDANVILLEPA17822240795959501(C)3$25,000RESIDENCY EXPANSION GRANT
BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
506 S WRIGHT STREETURBANAIL61801376000511STATE AGENCY$25,000RESIDENCY EXPANSION GRANT
PARKVIEW HOSPITAL INC
11109 PARKVIEW PLAZA DRIVEFORT WAYNEIN46845350868085501(C)3$25,000RESIDENCY EXPANSION GRANT
UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION
22 SOUTH GREENE STREETBALTIMOREMD21201521362793501(C)3$25,000RESIDENCY EXPANSION GRANT
BAPTIST HEALTHCARE SYSTEM INC
2701 EASTPOINT PARKWAYLOUISVILLEKY40223610444707501(C)3$25,000RESIDENCY EXPANSION GRANT
FieldValueIRS element (for citing)
Total501c3 Org13Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmt
LITERATURE AWARD8$17,345
STUDENT LEADERSHIP AWARDS9$18,000

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (1)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsYes (1)CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
PAUL W ABRAMOWITZ
PRESIDENT/ASHP CEO$0$771,153$0$115,500$0$31,240$0$27,700$0$31,162$0$976,755$0$0
STEVEN A RUBLOFF
SECY/ASHP REF CEO$311,395$0$25,000$0$1,242$0$11,200$0$39,662$0$388,499$0$0$0
BARBARA NUSSBAUM
VP FOR RESEARCH AND EDUCATION$171,234$0$7,875$0$982$0$18,524$0$40,181$0$238,796$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 3THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED ORGANIZATION, USES THE FOLLOWING TO ESTABLISH COMPENSATION OF ITS CEO: COMPENSATION COMMITTEE, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, FORM 990 OF OTHER ORGANIZATIONS, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE.
PART I, LINE 6PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.
PART I, LINE 7ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 7ATHREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.
FORM 990, PART VI, SECTION A, LINE 8BTHERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD BEFORE IT IS FILED. EACH MEMBER HAS THE OPPORTUNITY TO REVIEW THE FORM 990.
FORM 990, PART VI, SECTION B, LINE 12CTHE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING
FORM 990, PART VI, SECTION B, LINE 15ACEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVALUATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE MAKES A REFLECTIVE REVIEW OF PERFORMANCE DURING THE CONTRACT PERIOD. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE REFLECTIVE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARD'S CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARMACIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.
FORM 990, PART VI, SECTION C, LINE 19THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.
FORM 990, PART IX, LINE 11GCONTRACT SERVICES: PROGRAM SERVICE EXPENSES 314,350. MANAGEMENT AND GENERAL EXPENSES 75,953. FUNDRAISING EXPENSES 30,131. TOTAL EXPENSES 420,434.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)BusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line14500 EAST-WEST HIGHWAY SUITE 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd
FieldValueIRS element (for citing)
EIN520807628EIN
Primary ActivitiesTO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSIONPrimaryActivitiesTxt
Legal Domicile StateMDLegalDomicileStateCd
Exempt Code Section501(C)(6)ExemptCodeSectionTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (1)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other OrgYes (1)TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (5 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
C$357,100CASH
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
N$509,291RECORDED EXPENSES
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
O$180,698FAIR VALUE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
P$1,704,011RECORDED EXPENSES
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
S$1,194,721CASH

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.